Skip to main content
. 2017 Apr 19;2017:9547902. doi: 10.1155/2017/9547902

Table 2.

Genotypic and allelic distribution of the NLRP1 gene between all patients (n = 163) and controls (n = 201).

SNP Genotype/allele Case (%) Control (%) p valuea(χ2) OR (95% CI) p valueb
rs8079034 CC 120 (73.6) 153 (76.1) 0.752 (0.569) 1.00 Referent
CT 37 (22.7) 43 (21.4) 0.911 (0.553–1.503) 0.717
TT 6 (3.7) 5 (2.5) 0.654 (0.195–2.193) 0.491
CT + TT 43 (26.4) 48 (23.9) 0.584 (0.300) 0.876 (0.544–1.409) 0.584
C 277 (85.0) 349 (86.8) 0.475 (0.509) 1.00 Referent
T 49 (15.0) 53 (13.2) 0.858 (0.565–1.306) 0.476

rs878329 GG 123 (75.5) 121 (60.2) 0.009 (9.486) 1.00 Referent
GC 35 (21.5) 70 (34.8) 2.033 (1.262–3.276) 0.004
CC 5 (3.0) 10 (5.0) 2.033 (0.675–6.123) 0.207
GC + CC 40 (24.5) 80 (39.8) 0.002 (9.486) 2.033 (1.290–3.204) 0.002
G 281 (86.2) 312 (77.6) 0.003 (8.782) 1.00 Referent
C 45 (13.8) 90 (22.4) 1.801 (1.217–2.667) 0.003

CI, confidence interval; OR, odds ratio.

a p value for genotype and allele frequencies in cases and controls using 2-sided χ2 test.

b p values adjusted by age and gender using logistic regression.

p < 0.05.